MMEA
Main Management ETF Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $963K | Buy |
19,791
+324
| +2% | +$15.8K | 0.04% | 90 |
|
|
2025
Q1 | $662K | Buy |
19,467
+5,939
| +44% | +$202K | 0.03% | 108 |
|
|
2024
Q4 | $532K | Sell |
13,528
-1,216
| -8% | -$47.8K | 0.02% | 137 |
|
|
2024
Q3 | $693K | Buy |
+14,744
| New | +$693K | 0.03% | 132 |
|